Mood Evidence has linked depression with B-12 deficiency
Abstract Central nervous system (CNS) disorders, such as psychiatric disorders, neurodegeneration, chronic pain, stroke, brain tumor, spinal cord injury, and many other CNS diseases, would hugely benefit from specific and potent peptide pharmaceuticals and their low inherent toxicity
(IV) Elucidate the exact mechanism of MG stress, oxidative stress and chronic inflammation cross-linking network in the construction of tumor microenvironment, and to identify the key nodes of MG-related signaling pathways in the dynamic evolution of the tumor microenvironment, so as to develop effective intervention strategies
This same agent, SHU 9119, also appears to have inhibited the depressor response that was probably produced by melanocortin agonists